生存率-话题@MedSci

#生存率#

482篇内容 | 3123人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1256765, encodeId=36181256e654d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Hepatology：血清可利用维生素D的浓度与肝细胞癌的生存率有关 , objectType=article, longId=193984, objectId=bb0a19398439, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb0a19398439, replyNumber=0, likeNumber=72, createdTime=2020-05-13, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb0a19398439, moduleTitle=Hepatology：血清可利用维生素D的浓度与肝细胞癌的生存率有关 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb0a19398439)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256764, encodeId=01191256e64bf, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Chest：非小细胞肺癌按农村、分期进行分层的治疗方式和生存率, objectType=article, longId=193846, objectId=ff8b193846ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff8b193846ae, replyNumber=0, likeNumber=46, createdTime=2020-05-11, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff8b193846ae, moduleTitle=Chest：非小细胞肺癌按农村、分期进行分层的治疗方式和生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff8b193846ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256763, encodeId=2e571256e6380, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=仅0.8%心脏肿瘤为原发恶性肿瘤，5年生存率不足12%！JACC美国癌症数据, objectType=article, longId=193710, objectId=c91d193e10e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c91d193e10e6, replyNumber=0, likeNumber=56, createdTime=2020-05-09, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c91d193e10e6, moduleTitle=仅0.8%心脏肿瘤为原发恶性肿瘤，5年生存率不足12%！JACC美国癌症数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c91d193e10e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256762, encodeId=a28b1256e6247, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Sci Rep：氧化磷酸化基因高表达可预测肺部鳞状细胞癌的生存率改善, objectType=article, longId=192846, objectId=0721192846c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0721192846c9, replyNumber=0, likeNumber=17, createdTime=2020-04-25, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0721192846c9, moduleTitle=Sci Rep：氧化磷酸化基因高表达可预测肺部鳞状细胞癌的生存率改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0721192846c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256761, encodeId=29951256e6168, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=上海发布全新数据：癌症患病率3% 5年生存率年均增长1%, objectType=article, longId=192802, objectId=6a671928020c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a671928020c, replyNumber=0, likeNumber=122, createdTime=2020-04-24, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a671928020c, moduleTitle=上海发布全新数据：癌症患病率3% 5年生存率年均增长1%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a671928020c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256760, encodeId=6d4f1256e6049, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=DCR：新辅助放化疗和全直肠系膜切除术后，辅助化学疗法不能改善2期或3期直肠癌患者的无复发生存率, objectType=article, longId=192550, objectId=2bcf192550e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bcf192550e6, replyNumber=0, likeNumber=53, createdTime=2020-04-21, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bcf192550e6, moduleTitle=DCR：新辅助放化疗和全直肠系膜切除术后，辅助化学疗法不能改善2期或3期直肠癌患者的无复发生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bcf192550e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256759, encodeId=12ba1256e595c, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JCO：肿瘤沉积可能降低Ⅲ期结肠癌的无病生存率, objectType=article, longId=192311, objectId=e0d0192311da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0d0192311da, replyNumber=0, likeNumber=79, createdTime=2020-04-16, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0d0192311da, moduleTitle=JCO：肿瘤沉积可能降低Ⅲ期结肠癌的无病生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0d0192311da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256758, encodeId=868d1256e5852, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JCO：三阴性乳腺癌治疗“中国方案”全球首发，患者5年无病生存率提升6%（CBCSG010研究）, objectType=article, longId=192030, objectId=e87b192030fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e87b192030fa, replyNumber=0, likeNumber=61, createdTime=2020-04-13, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e87b192030fa, moduleTitle=JCO：三阴性乳腺癌治疗“中国方案”全球首发，患者5年无病生存率提升6%（CBCSG010研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e87b192030fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256757, encodeId=56811256e5736, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Radiology：结直肠癌肺转移射频消融后的3年生存率有多高?, objectType=article, longId=192010, objectId=a99d19201088, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a99d19201088, replyNumber=0, likeNumber=81, createdTime=2020-04-12, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a99d19201088, moduleTitle=Radiology：结直肠癌肺转移射频消融后的3年生存率有多高?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a99d19201088)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256756, encodeId=c2da1256e568e, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Dig Liver Dis：他汀类药物可改善胰腺导管腺癌患者的生存率 , objectType=article, longId=191486, objectId=4fc819148698, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fc819148698, replyNumber=0, likeNumber=62, createdTime=2020-04-06, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fc819148698, moduleTitle=Dig Liver Dis：他汀类药物可改善胰腺导管腺癌患者的生存率 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4fc819148698)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256755, encodeId=b4871256e5577, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Heart：严重主动脉瓣狭窄患者主动脉瓣置换后的左心室充盈压和生存率, objectType=article, longId=191039, objectId=1261191039d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1261191039d5, replyNumber=0, likeNumber=148, createdTime=2020-03-30, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1261191039d5, moduleTitle=Heart：严重主动脉瓣狭窄患者主动脉瓣置换后的左心室充盈压和生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1261191039d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256754, encodeId=f7861256e54de, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA Cardiol：老年晚期心衰患者中与植入式心脏复律除颤器相关的围手术期风险和生存率, objectType=article, longId=191022, objectId=fbe01910221e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbe01910221e, replyNumber=0, likeNumber=71, createdTime=2020-03-30, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbe01910221e, moduleTitle=JAMA Cardiol：老年晚期心衰患者中与植入式心脏复律除颤器相关的围手术期风险和生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbe01910221e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256753, encodeId=3ebc1256e53a8, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Clin Med：高强度间歇训练与心力衰竭患者长期生存率提高相关, objectType=article, longId=190447, objectId=420e19044e29, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=420e19044e29, replyNumber=0, likeNumber=58, createdTime=2020-03-21, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=420e19044e29, moduleTitle=J Clin Med：高强度间歇训练与心力衰竭患者长期生存率提高相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=420e19044e29)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256752, encodeId=d0a31256e522b, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=喜大普奔！中国PD-L1免疫疗法惠及III期肺癌患者，5年生存率或超50%, objectType=article, longId=189360, objectId=4814189360cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4814189360cb, replyNumber=0, likeNumber=75, createdTime=2020-03-06, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4814189360cb, moduleTitle=喜大普奔！中国PD-L1免疫疗法惠及III期肺癌患者，5年生存率或超50%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4814189360cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256751, encodeId=b5e31256e5190, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=AJG：胆红素及碱性磷酸酶水平与原发性胆源性胆管炎生存率有关, objectType=article, longId=188588, objectId=d5dc1885888f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5dc1885888f, replyNumber=0, likeNumber=70, createdTime=2020-02-24, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5dc1885888f, moduleTitle=AJG：胆红素及碱性磷酸酶水平与原发性胆源性胆管炎生存率有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5dc1885888f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256750, encodeId=453c1256e5063, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Heart：主动脉瓣置换术的严重主动脉瓣狭窄患者左心室充盈压与生存率, objectType=article, longId=188357, objectId=e64a18835e97, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e64a18835e97, replyNumber=0, likeNumber=78, createdTime=2020-02-20, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e64a18835e97, moduleTitle=Heart：主动脉瓣置换术的严重主动脉瓣狭窄患者左心室充盈压与生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e64a18835e97)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256749, encodeId=39931256e49f9, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Clinica Chimica Acta：使用一种新的指数来预测原发性肝癌切除后的总生存率, objectType=article, longId=188337, objectId=fe3118833e6e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe3118833e6e, replyNumber=0, likeNumber=83, createdTime=2020-02-20, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe3118833e6e, moduleTitle=Clinica Chimica Acta：使用一种新的指数来预测原发性肝癌切除后的总生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe3118833e6e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256748, encodeId=e75f1256e4815, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J INTERN MED：结肠直肠癌家族史与患者生存率, objectType=article, longId=187745, objectId=029018e745ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=029018e745ae, replyNumber=0, likeNumber=78, createdTime=2020-02-11, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=029018e745ae, moduleTitle=J INTERN MED：结肠直肠癌家族史与患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=029018e745ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256747, encodeId=8aab1256e475e, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关, objectType=article, longId=187720, objectId=ddb118e72078, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddb118e72078, replyNumber=0, likeNumber=70, createdTime=2020-02-10, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddb118e72078, moduleTitle=2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddb118e72078)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256746, encodeId=60711256e4684, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Gastroenterology：治疗代偿性腹水可减轻肌肉减少症并改善失代偿性肝硬化患者的生存率, objectType=article, longId=187607, objectId=e94e18e6078b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e94e18e6078b, replyNumber=0, likeNumber=59, createdTime=2020-02-08, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e94e18e6078b, moduleTitle=J Gastroenterology：治疗代偿性腹水可减轻肌肉减少症并改善失代偿性肝硬化患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e94e18e6078b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存率

2020-05-29

柳叶一刀 (审核中...)

前往app查看评论内容

#生存率#

Hepatology：血清可利用维生素D的浓度与肝细胞癌的生存率有关

2020-05-13

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Chest：非小细胞肺癌按农村、分期进行分层的治疗方式和生存率

2020-05-11

guoyibin (审核中...)

前往app查看评论内容

#生存率#

仅0.8%心脏肿瘤为原发恶性肿瘤，5年生存率不足12%！JACC美国癌症数据

2020-05-09

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Sci Rep：氧化磷酸化基因高表达可预测肺部鳞状细胞癌的生存率改善

2020-04-25

guoyibin (审核中...)

前往app查看评论内容

#生存率#

上海发布全新数据：癌症患病率3% 5年生存率年均增长1%

2020-04-24

guoyibin (审核中...)

前往app查看评论内容

#生存率#

DCR：新辅助放化疗和全直肠系膜切除术后，辅助化学疗法不能改善2期或3期直肠癌患者的无复发生存率

2020-04-21

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JCO：肿瘤沉积可能降低Ⅲ期结肠癌的无病生存率

2020-04-16

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JCO：三阴性乳腺癌治疗“中国方案”全球首发，患者5年无病生存率提升6%（CBCSG010研究）

2020-04-13

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Radiology：结直肠癌肺转移射频消融后的3年生存率有多高?

2020-04-12

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Dig Liver Dis：他汀类药物可改善胰腺导管腺癌患者的生存率

2020-04-06

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Heart：严重主动脉瓣狭窄患者主动脉瓣置换后的左心室充盈压和生存率

2020-03-30

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA Cardiol：老年晚期心衰患者中与植入式心脏复律除颤器相关的围手术期风险和生存率

2020-03-30

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Clin Med：高强度间歇训练与心力衰竭患者长期生存率提高相关

2020-03-21

guoyibin (审核中...)

前往app查看评论内容

#生存率#

喜大普奔！中国PD-L1免疫疗法惠及III期肺癌患者，5年生存率或超50%

2020-03-06

guoyibin (审核中...)

前往app查看评论内容

#生存率#

AJG：胆红素及碱性磷酸酶水平与原发性胆源性胆管炎生存率有关

2020-02-24

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Heart：主动脉瓣置换术的严重主动脉瓣狭窄患者左心室充盈压与生存率

2020-02-20

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Clinica Chimica Acta：使用一种新的指数来预测原发性肝癌切除后的总生存率

2020-02-20

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J INTERN MED：结肠直肠癌家族史与患者生存率

2020-02-11

guoyibin (审核中...)

前往app查看评论内容

#生存率#

2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关

2020-02-10

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Gastroenterology：治疗代偿性腹水可减轻肌肉减少症并改善失代偿性肝硬化患者的生存率

2020-02-08

科室
- - 订阅+
  - 更多科室
工具
服务